It's Jim Kramer here.

You're listening to the opening bell of CBC Squawk on the Street.

Don't miss a minute of the action.

Good Monday morning.

Welcome to Squawk on the Street.

I'm Carl Kington here with David Faber.

Courtney Reagan's back here at Post 9 of the New York Stock Exchange.

Sarah Eisen has the

morning off. We are in the process of testing that earlier March low briefly fell below 5,500

this morning as we are setting up for a busy week, whether that's tariffs, a jobs number,

some commentary from the Fed chair, and more. Yeah, what a week this is going to be. We are 30 minutes into the trading session on this Monday morning, so here are the three big movers that we are watching to cut us off. Another firm cutting its price target on Tesla Steifle going from 474 to 455. In a new note this morning, citing a slowdown in the first quarter deliveries and headwinds from Tesla protests. You can see shares down 5%. Invidia shares under pressure again, too, on pace for its worst quarter.

And more than two years down more than 20% year-to-date.

We'll take a closer look at the chip giant.

That in just a moment, shares down by 4% in vaccine makers getting crushed,

following the resignation of the FDA's top vaccine regulator, Dr. Peter Marks,

who went on to criticize helping Human Services Secretary, RFK, in his resignation.

You can see there on Moderna down almost 13%.

Wow, those names are really getting hit.

Yeah, a lot of concern about vaccines in general, as our viewers likely know.

All right, we're just a few days away from President Trump's new tariffs being announced

and many going into effect, including what would be a 25% levy on all automobiles that are

not made in the United States.

...